Zum Inhalt

Pharmaceutical Medicine

Ausgabe 5/2025

Inhalt (8 Artikel)

Transforming Care in China by Using Public–Private Partnerships to Unlock the Power of Patient-Centered Real-World Data

  • Open Access
  • Current Opinion

Maigeng Zhou, Feng Sun, Fuzhong Xue, Lena Sjögren, Shirley Xiao, Shaosen Zhang, Pingyan Chen, Siyan Zhan, Alexander Bedenkov

Utilization of Evidence Blueprint Initiative to Transform Capability Development in AstraZeneca Spain

  • Open Access
  • Current Opinion

Jesús Medina, Joaquín Sánchez-Covisa, Javier Nuevo, Beatriz Palacios, Ana Roncero, Marta Alegría, Joana Gostkorzewicz, Antonio Velasco, Kristoffer Larsen, Marta Moreno, César Velasco, Ana Pérez Domínguez

Pioneering the Future of Medical Affairs: A Strategic Transformation to Meet the Spanish Healthcare Ecosystem’s Evolving Trends

  • Open Access
  • Leading Article

Ana Pérez Domínguez, Jorge Marinich, Gema Monteagudo, Carmen Moreno, Lucía Regadera, Inmaculada Iglesias

Combating Antimicrobial Resistance: Role of Key Stakeholders with Focus on the Pharmaceutical Sector

  • Review Article

Sangeeta Sharma, Maneesh Paul Satyaseela, Ranga Reddy Burri, Ratnakar Palakodeti, Deepika Pamarthy

A Framework for Considering the Role of the Public Sector in R&D of Health Technology

  • Open Access
  • Review Article

Juan Carlos Rejon-Parrilla, David Epstein, Jorge Mestre-Ferrandiz, Jaime Espin

Developing Biosimilars: Challenges and Opportunities

  • Review Article

Shubhadeep Sinha, Ruby Raphael

Safety Warnings on the Same Harmful Effects of Medicines: A Comparison of Four National Regulators

  • Open Access
  • Original Research Article

Lucy T. Perry, Alice Bhasale, Ashleigh Hooimeyer, Eliza J. McEwin, Annim Mohammad, Barbara Mintzes

Treatment Persistence in Rheumatoid Arthritis Before and After Etanercept Biosimilar Introduction: A Nationwide Australian Real-World Study

  • Open Access
  • Original Research Article

Chin Hang Yiu, Bella D. Ianni, Richard O. Day, Jacques Raubenheimer, Christine Y. Lu